U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H35N6O8P
Molecular Weight 602.576
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of REMDESIVIR

SMILES

CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C2=CC=C3N2N=CN=C3N)OC4=CC=CC=C4

InChI

InChIKey=RWWYLEGWBNMMLJ-YSOARWBDSA-N
InChI=1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1

HIDE SMILES / InChI
Molecular Formula C27H35N6O8P
Molecular Weight 602.576
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

2020
691
Substance Class Chemical
Created
by admin
on Wed Apr 02 13:38:29 GMT 2025
Edited
by admin
on Wed Apr 02 13:38:29 GMT 2025
Record UNII
3QKI37EEHE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
REMDESIVIR
INN  
INN   USAN  
Official Name English
L-ALANINE, N-((S)-HYDROXYPHENOXYPHOSPHINYL)-, 2-ETHYLBUTYL ESTER, 6-ESTER WITH 2-C-(4-AMINOPYRROLO(2,1-F)(1,2,4)TRIAZIN-7-YL)-2,5-ANHYDRO-D-ALTRONONITRILE
Preferred Name English
2-ETHYLBUTYL (2S)-2-(((2R, 3S, 4R, 5R)-5-(4-AMINOPYRROLO(2,1-F) (1,2,4)TRIAZIN-7-YL)-5-CYANO-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL) METHOXY)(PHENOXY) PHOSPHORYL) AMINO) PROPANOATE
Systematic Name English
VEKLURY
Brand Name English
REMDESIVIR [JAN]
Common Name English
Remdesivir [WHO-DD]
Common Name English
GS-5734
Code English
REMDESIVIR [USAN]
Common Name English
REMDESIVIR [ORANGE BOOK]
Common Name English
2-ETHYLBUTYL (2S)-2-(((S)-(((2R,3S,4R,5R)-5-(4-AMINOPYRROLO(2,1-F)(1,2,4)TRIAZIN-7-YL)-5-CYANO-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHOXY)(PHENOXY)PHOSPHORYL)AMINO)PROPANOATE
Systematic Name English
2-ETHYLBUTYL N-((S)-(2-C-(4-AMINOPYRROLO(2,1-F)(1,2,4)TRIAZIN-7-YL)-2,5-ANHYDRO-D-ALTRONONITRIL-6-O-YL)PHENOXYPHOSPHORYL)-L-ALANINATE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C281
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
EU-Orphan Drug EU/3/16/1615
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
FDA ORPHAN DRUG 490515
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
FDA ORPHAN DRUG 739020
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
Code System Code Type Description
CHEBI
145994
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
DRUG CENTRAL
5376
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
INN
10478
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
FDA UNII
3QKI37EEHE
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
RXCUI
2284718
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
PUBCHEM
121304016
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
NCI_THESAURUS
C152185
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
DAILYMED
3QKI37EEHE
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
USAN
FG-60
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
EPA CompTox
DTXSID701022537
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
SMS_ID
100000181868
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
DRUG BANK
DB14761
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
CAS
1355050-11-1
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
NON-SPECIFIC STEREOCHEMISTRY
WIKIPEDIA
GS-5734
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
CAS
1809249-37-3
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
LACTMED
Remdesivir
Created by admin on Wed Apr 02 13:38:29 GMT 2025 , Edited by admin on Wed Apr 02 13:38:29 GMT 2025
PRIMARY
Related Record Type Details
Structure of REMDESIVIR
EXCRETED UNCHANGED
URINE
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
Structure of 2-Ethylbutyl L-Alaninate Hydrochloride
STARTING MATERIAL -> INGREDIENT
LYSOSOMAL PROTECTIVE PROTEIN
METABOLIC ENZYME -> SUBSTRATE
LIVER CARBOXYLESTERASE 1
METABOLIC ENZYME -> SUBSTRATE
MAJOR
CYTOCHROME P450 3A4
METABOLIC ENZYME -> INHIBITOR
MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1
TRANSPORTER -> INHIBITOR
CYTOCHROME P450 3A4
METABOLIC ENZYME -> SUBSTRATE
SARS-COV
TARGET ORGANISM->INHIBITOR
In human airway epithelial cells
MERS-COV
TARGET ORGANISM->INHIBITOR
In human airway epithelial cells
EC50
SARS-COV2
TARGET ORGANISM->INHIBITOR
In Vero E6 cells inhibits. Targets the RNA-dependent RNA polymerase and block viral RNA synthesis in a broad spectrum of RNA viruses, including human coronaviruses. A US patient with 2019-nCoV recovered after receiving intravenous remdesivir in January
BIOASSAY (CELLULAR)
EC50
MULTIDRUG RESISTANCE PROTEIN 1
TRANSPORTER -> SUBSTRATE
OATP1B1
TRANSPORTER -> INHIBITOR
OATP-8
TRANSPORTER -> INHIBITOR
Related Record Type Details
Structure of GS-441524
METABOLITE ACTIVE -> PRODRUG
Structure of GS-441524 monophosphate
METABOLITE ACTIVE -> PRODRUG
Structure of GS-441524 TRIPHOSPHATE
METABOLITE ACTIVE -> PRODRUG
Related Record Type Details
Structure of REMDESIVIR
ACTIVE MOIETY
Structure of Des-phenyl-remdesivir
ACTIVE MOIETY (FOR EXCLUSIVITY)
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Tmax PHARMACOKINETIC
Blood-to-plasma ratio PHARMACOKINETIC
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966